Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rabia Anselm"'
Autor:
Anil K Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, Jennifer Moore, Rudrani Banerjee, Phillip Yates, Jill Walker, Gretja Schnell, Mary Beth Connolly, Andrea L Cathcart, Varsha Imber, Rabia Anselm, Lindsay Winograd, Nancy Haeusser, Scott Segal, Andrew Skingsley, Melissa Aldinger, Amanda Peppercorn, Jaynier Moya
Publikováno v:
Open Forum Infectious Diseases. 9
Background There is a continued need for therapeutics for the treatment of COVID-19, including intramuscular (IM) agents, which will enable broader use across a variety of healthcare delivery settings. Methods COMET-PEAK (NCT04779879) is a 3-part stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a81441c48c45a176a512696de62e697
https://doi.org/10.1093/ofid/ofac492.992
https://doi.org/10.1093/ofid/ofac492.992
Autor:
Christopher J. Delves, Caroline O. S. Savage, Tim S. Schmidt, Lea Fortunato, Emilie Charles, Thomas Matthew Webb, Lia Liefaard, Nicolas Wisniacki, John Stone, Rainard Fuhr, Sara Brett, Stephen A. Hughes, Ruth M. Tarzi, Muna Albayaty, Christine Barrett, Ken Edwards, Karen Leavens, Katherine Nevin, Rabia Anselm, Joanne Ellis, Shuo Tang, Martin Coenen, T.G. Hopkins, N Srinivasan, Yi Cui, Daniel J.B. Marks, Anna Richards, Maria Feeney
Publikováno v:
Clinical Pharmacology & Therapeutics. 109:1293-1303
Activated T cells drive a range of immune-mediated inflammatory diseases. LAG-3 is transiently expressed on recently activated CD4+ and CD8+ T cells. We describe the engineering and first-in-human clinical study (NCT02195349) of GSK2831781 (an afucos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f62756dd9fb9176467d5ec91c6f2f47a
https://doi.org/10.1002/cpt.2091
https://doi.org/10.1002/cpt.2091
Autor:
Joanne, Ellis, Daniel, J B Marks, Naren, Srinivasan, Christine, Barrett, Thomas G, Hopkins, Anna, Richards, Rainard, Fuhr, Muna, Albayaty, Martin, Coenen, Lia, Liefaard, Karen, Leavens, Katherine L, Nevin, Shuo, Tang, Stephen A, Hughes, Léa, Fortunato, Ken, Edwards, Yi, Cui, Rabia, Anselm, Christopher J, Delves, Emilie, Charles, Maria, Feeney, Thomas M, Webb, Sara J, Brett, Tim S, Schmidt, John, Stone, Caroline O S, Savage, Nicolas, Wisniacki, Ruth M, Tarzi
Publikováno v:
Clinical Pharmacology and Therapeutics
Activated T cells drive a range of immune‐mediated inflammatory diseases. LAG‐3 is transiently expressed on recently activated CD4+ and CD8+ T cells. We describe the engineering and first‐in‐human clinical study (NCT02195349) of GSK2831781 (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f23427490f0b1e1cb4970397cb5df0a0
https://pubmed.ncbi.nlm.nih.gov/33113155
https://pubmed.ncbi.nlm.nih.gov/33113155